Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
3.980
-0.030 (-0.75%)
At close: May 12, 2025, 4:00 PM
3.950
-0.030 (-0.75%)
After-hours: May 12, 2025, 6:37 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $15.00 million as of May 12, 2025. Its market cap has increased by 185.11% in one year.
Market Cap
15.00M
Enterprise Value
10.56M
1-Year Change
185.11%
Ranking
Category
Stock Price
$3.98
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $15.00M, a decrease of -76.67%. That is a compound annual growth rate of -34.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 15.11M | -7.17% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |